Early detection and accuracy have been significantly improved by recent advancements in dementia diagnosis. Neuroimaging techniques such as MRI and PET scans help detect early indicators of neurodegeneration and provide valuable information on the structure and function of the brain. Amyloid beta and tau proteins are two examples of biomarkers that can be found in blood or cerebrospinal fluid to monitor the course of a disease. Additionally, cognitive evaluations and neuropsychological exams aid in identifying certain deficiencies and assessing cognitive capacities. Healthcare professionals can identify patients more accurately by combining these methods, which may allow for earlier interventions that could reduce the disease's progression.
Track 14-1: Genetic Testing
Track 14-2: Artificial Intelligence and Machine Learning
Track 14-3: Cognitive Assessment Tools
Track 14-4: Biomarkers
Track 14-5: Neuroimaging
All accepted abstracts will be published in respective Allied Academies Journals.
Abstracts will be provided with Digital Object Identifier by
